Protective Effect of Notoginsenoside R1 on an APP/PS1 Mouse Model of Alzheimer&aposs Disease by Up-Regulating Insulin Degrading Enzyme and Inhibiting A&bgr; Accumulation

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 3, 2015-04 ,pp. : 360-369

Bentham Science Publishers

Access to resources Recommend Favorite

Rosiglitazone Improves Spatial Memory and Decreases Insoluble Aβ 1-42 in APP/PS1 Mice

By O'Reilly Julie-Ann  

Journal of Neuroimmune Pharmacology, Vol. 7, Iss. 1, 2012-03 ,pp. : 140-144

Springer Publishing Company

Access to resources Recommend Favorite

Functional Autoradiography Shows Unaltered Cannabinoid CB1 Receptor Signalling in Hippocampus and Cortex of APP/PS1 Transgenic Mice

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 8, 2012-12 ,pp. : 1038-1044

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Amyloid Effects of Small Molecule A&bgr;-Binding Agents in PS1/APP Mice

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 6, 2009-09 ,pp. : 437-444

Bentham Science Publishers

Access to resources Recommend Favorite

Evidence for the role of nitric oxide in caffeine-induced locomotor activity in mice

By Kayir Hakan   Uzbay I.  

Psychopharmacology, Vol. 172, Iss. 1, 2004-02 ,pp. : 11-15

Springer Publishing Company

Access to resources Recommend Favorite